References
- Kumazawa Y., Takimoto H., Miura S., Nishimura C., Yamada A., Kawakita T., Nomoto K. Activation of murine peritoneal macrophage by intraperitoneal administration of traditional Chinese herbal medicine, xiao-chai-hu-tang (Japanese name: shosaiko-to). Int. J. Immunopharmac. 1988; 10: 395
- Kawakita T., Yamada A., Mitsuyama M., Kumazawa Y., Nomoto K. Protective effect of a traditional Chinese medicine, xiao-chai-hu-tang (Japanese name: shosaiko-to), on Psuedomonas aeruginosa infection in mice. Immunopharm. Immunotox. 1987; 9: 523
- Kawakita T., Yamada A., Mitsuyama M., Kumazawa Y., Nomoto K. Protective effect of a traditional Chinese medicine, xiao-chai-hu-tang (Japanese name: shosaiko-to), on Listeria monocytogenes infection in mice. Immunopharm. Immunotox. 1988; 10: 345
- Li X., Takimoto H., Miura S., Yoshikai Y., Matsuzaki G., Nomoto K. Effect of a traditional Chinese medicine, bu-zhong-yi-qi-tang (Japanese name: hochu-ekki-to) on the protection against Listeria monocytogenes infection in mice. Immunopharm. Immunotox. 1992; 14: 383
- Aburada M., Takeda S., Ito E., Nakamura M., Hosoya E. Protective effects of Juzentaihoto, dried decoctum of 10 Chinese herbs mixture, upon the adverse effects of Mitomycin C in mice. J. Pharm. Dyn. 1983; 6: 1000
- Miura S., Kawamura I., Yamada A., Kawakita T., Kumazawa Y., Himeno K., Nomoto K. Effect of a traditional Chinese herbal medicine, ren-sheng-yang-rong-tang (Japanese name: ninjin-youei-to) on hematopoietic stem cells in mice. Int. J. Immunopharmac. 1989; 11: 771
- Haranaka K., Satomi N., Sakurai A., Haranaka R., Okada N., Kobayashi M. Antitumor activity and tumor necrosis factor productivity of traditional Chinese medicines and crude drugs. Cancer Immunol. Immunother. 1985; 20: 1
- Hamada M., Fujii Y., Yamamoto H., Miyazawa Y., Shui S. M., Tung Y. C., Yamaguchi N. Effect of a kampo medicine, zyuzentaiho-to, on the immune reactivity of tumor-bearing mice. J. Ethnopharmac. 1988; 24: 311
- Haranaka R., Hasegawa R., Nakagawa S., Sakumi A., Satomi N., Haranaka K. Antitumor activity of combination therapy with traditional Chinese medicine and OK432 or MMC. J. Biol. Response Modif. 1988; 7: 77
- Cho J., Sato N., Kikuchi K. Prophylactic anti-tumor effect of hochu-ekki-to (TJ-41) by enhancing natural killer cell activity. In Vivo 1991; 5: 389
- Kaneko M., Kawakita T., Tauchi Y., Saito T., Suzuki A., Nomoto K. Augmentation of NK activity after oral administration of a traditional Chinese medicine, xiao-chai-hu-tang (shosaiko-to). Immunopharm. Immunotox. 1994; 16: 41
- Kawakita T., Nakai S., Kumazawa Y., Miura O., Yumioka E., Nomoto K. Induction of interferon after administration of a traditional Chinese medicine, xiao-chai-hu-tang (shosaiko-to) Int. J. Immunopharmac. 1990; 12: 515
- Matsomoto T., Himeno K., Mitani M., Mori M., Mori K., Miake S., Nomoto K. Differing contribution of various effector cells in the elimination of syngeneic or allogeneic cells. J. Clin. Lab. Immunol. 1986; 19: 83
- Winn H. J. Immune mechanisms in homotransplantation. II. Quantitative assay of the immunologic activity of lymphoid cells stimulated by tumor homograft. J. Immunol. 1961; 86: 228
- Yoshizawa H., Chang A. E., Shu S. Specific adoptive immunotherapy mediated by tumor-draining lymph node cells sequentially activated with anti-CD3 and IL-2. J. Immunol. 1991; 147: 729
- Okamoto T., Harada M., Shinomiya Y., Matsuzaki G., Nomoto K. The antitumor effect of tumor-draining lymph node cells activated by both anti-CD3 monoclonal antibody and activated B cells as costimulatory signal-providing cells. Caner Immunol. Immunother. 1995, in press
- Mitani M., Mori K., Himeno K., Matsumoto Y., Taniguchi K., Nomoto K. The role of cytostasis in antitumor immunity: Comparison between syngeneic and allogeneic systems. Cell. Immunol. 1985; 92: 22
- Mosmann T. R., Schumacher J. H., Street N. F., Budd R., O'garra A., Fong T. AT., Bond M. W., Moore K. W. M., Sher A., Fiorentino D. F. Diversity of cytokine synthesis and function of mouse CD4+ T cells. Immunol. Rev. 1991; 123: 209
- Nagarkatti M., Clary S. R., Nagarkatti P. S. Characterization of tumor-infiltrating CD4+ T cells as Th1 cells based on lymphokine secretion and functional properties. J. Immunol. 1990; 144: 4898
- Harada M., Matsuzaki G., Yoshikai Y., Kobayashi N., Kurosawa S., Takimoto H., Nomoto K. Autoreactive and heat shock protein 60-recognizing CD4+ T cells show antitumor activity against syngeneic fibrosarcoma. Cancer Res. 1993; 53: 106
- North R. J., Bursuker I. Generation and decay of the immune response to a progressive fibrosarcoma. I. Ly 1+2− suppressor T cells down-regulate the generation of Ly-1−2+ effector T cells. J. Exp. Med. 1984; 159: 1295